South Korea · Delayed Price · Currency is KRW Bio Solution Statistics
Total Valuation
Bio Solution has a market cap or net worth of KRW 183.21 billion. The enterprise value is 191.48 billion.
| Market Cap | 183.21B |
| Enterprise Value | 191.48B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Solution has 25.80 million shares outstanding. The number of shares has increased by 0.82% in one year.
| Current Share Class | 25.80M |
| Shares Outstanding | 25.80M |
| Shares Change (YoY) | +0.82% |
| Shares Change (QoQ) | +1.27% |
| Owned by Insiders (%) | 17.71% |
| Owned by Institutions (%) | 0.00% |
| Float | 21.23M |
Valuation Ratios
The trailing PE ratio is 262.86.
| PE Ratio | 262.86 |
| Forward PE | n/a |
| PS Ratio | 11.58 |
| PB Ratio | 4.37 |
| P/TBV Ratio | 4.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 292.38 |
| EV / Sales | 12.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 0.46.
| Current Ratio | 0.81 |
| Quick Ratio | 0.73 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | -13.32 |
| Interest Coverage | -1.51 |
Financial Efficiency
Return on equity (ROE) is 1.79% and return on invested capital (ROIC) is -4.29%.
| Return on Equity (ROE) | 1.79% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -4.29% |
| Return on Capital Employed (ROCE) | -9.61% |
| Weighted Average Cost of Capital (WACC) | 4.28% |
| Revenue Per Employee | 77.95M |
| Profits Per Employee | 3.23M |
| Employee Count | 203 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.61% in the last 52 weeks. The beta is -0.13, so Bio Solution's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -36.61% |
| 50-Day Moving Average | 9,911.20 |
| 200-Day Moving Average | 9,082.30 |
| Relative Strength Index (RSI) | 30.47 |
| Average Volume (20 Days) | 179,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Solution had revenue of KRW 15.82 billion and earned 654.91 million in profits. Earnings per share was 27.01.
| Revenue | 15.82B |
| Gross Profit | 9.98B |
| Operating Income | -4.26B |
| Pretax Income | 654.91M |
| Net Income | 654.91M |
| EBITDA | -1.93B |
| EBIT | -4.26B |
| Earnings Per Share (EPS) | 27.01 |
Balance Sheet
The company has 11.21 billion in cash and 19.48 billion in debt, with a net cash position of -8.27 billion or -320.50 per share.
| Cash & Cash Equivalents | 11.21B |
| Total Debt | 19.48B |
| Net Cash | -8.27B |
| Net Cash Per Share | -320.50 |
| Equity (Book Value) | 41.94B |
| Book Value Per Share | 1,707.65 |
| Working Capital | -4.08B |
Cash Flow
In the last 12 months, operating cash flow was -1.22 billion and capital expenditures -240.60 million, giving a free cash flow of -1.46 billion.
| Operating Cash Flow | -1.22B |
| Capital Expenditures | -240.60M |
| Depreciation & Amortization | 2.33B |
| Net Borrowing | -934.80M |
| Free Cash Flow | -1.46B |
| FCF Per Share | -56.68 |
Margins
Gross margin is 63.09%, with operating and profit margins of -26.94% and 4.14%.
| Gross Margin | 63.09% |
| Operating Margin | -26.94% |
| Pretax Margin | 4.14% |
| Profit Margin | 4.14% |
| EBITDA Margin | -12.23% |
| EBIT Margin | -26.94% |
| FCF Margin | n/a |
Dividends & Yields
Bio Solution does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.82% |
| Shareholder Yield | -0.82% |
| Earnings Yield | 0.36% |
| FCF Yield | -0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 27, 2025. It was a forward split with a ratio of 3.
| Last Split Date | May 27, 2025 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Bio Solution has an Altman Z-Score of 4.41 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.41 |
| Piotroski F-Score | 3 |